Corpus callosum index and long-term disability in multiple sclerosis patients

Journal of Neurology

Volumn 257, Issue 8, 2010, Pages 1256-1264

  Yaldizli, Özgür ^a,b   Atefy, Ramin ^b   Gass, Achim ^a   Sturm, Dietrich ^b   Glassl, Stephanie ^b   Tettenborn, Barbara ^b   Putzki, Norman ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Atrophy; Corpus callosum; Disability; Disease modifying treatment; MRI; Multiple sclerosis

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT DURATION;

ADOLESCENT; ADULT; ATROPHY; COHORT STUDIES; CORPUS CALLOSUM; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS, MYELINATED; RETROSPECTIVE STUDIES; TIME; YOUNG ADULT;

EID: 77955922447     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5503-x     Document Type: Article

References (52)

1. VM Anderson NC Fox DH Miller 2006 Magnetic resonance imaging measures of brain atrophy in multiple sclerosis J Magn Reson Imaging 23 605 618 10.1002/jmri.20550 16596564
2. FJ Barkhof M Elton J Lindeboom, et al. 1998 Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study J Neurol 245 153 158 10.1007/s004150050196 1:STN:280:DyaK1c3hsVClsQ%3D%3D 9553845 (Pubitemid 28135058)
3. RA Bermel J Sharma CW Tjoa, et al. 2003 A semiautomated measure of whole-brain atrophy in multiple sclerosis J Neurol Sci 208 57 65 10.1016/S0022-510X(02)00425-2 12639726 (Pubitemid 36294155)
4. DT Chard CM Griffin GJ Parker, et al. 2002 Brain atrophy in clinically early relapsing-remitting multiple sclerosis Brain 125 327 337 10.1093/brain/awf025 1:STN:280:DC%2BD387hsVeksw%3D%3D 11844733
5. DT Chard CM Griffin W Rashid, et al. 2004 Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis Mult Scler 10 387 391 10.1191/1352458504ms1050oa 1:STN:280:DC%2BD2cvitFGqsg%3D%3D 15327034
6. C Confavreux S Vukusic P Adeleine 2003 Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process Brain 126 770 782 10.1093/brain/awg081 12615637 (Pubitemid 36372978)
7. CM Dalton KA Miszkiel PW O'Connor, et al. 2006 Ventricular enlargement in MS: one-year change at various stages of disease Neurology 66 693 698 10.1212/01.wnl.0000201183.87175.9f 1:STN:280:DC%2BD287ks1Sqsg%3D%3D 16534105 (Pubitemid 43739823)
8. N De Stefano M Battaglini SM Smith 2007 Measuring brain atrophy in multiple sclerosis J Neuroimaging 17 Suppl 1 10S 15S 10.1111/j.1552-6569.2007. 00130.x 17425728 (Pubitemid 46558262)
9. N De Stefano PM Matthews M Filippi, et al. 2003 Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 1157 1162 12682324
10. N Evangelou MM Esiri S Smith, et al. 2000 Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis Ann Neurol 47 391 395 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0. CO;2-J 1:STN:280:DC%2BD3c7nvFSjug%3D%3D 10716264 (Pubitemid 30141854)
11. FF Figueira VS Santos GM Figueira, et al. 2007 Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis Arq Neuropsiquiatr 65 931 935 18094848
12. M Filippi A Campi B Colombo, et al. 1996 A spinal cord MRI study of benign and secondary progressive multiple sclerosis J Neurol 243 502 505 10.1007/BF00886870 1:STN:280:DyaK28vjtl2muw%3D%3D 8836938 (Pubitemid 26239702)
13. M Filippi G Mastronardo MA Rocca, et al. 1998 Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis J Neurol Sci 158 148 153 10.1016/S0022-510X(98)00110-5 1:STN:280:DyaK1czmvVSltQ%3D%3D 9702685 (Pubitemid 28342078)
14. M Filippi DW Paty L Kappos, et al. 1995 Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study Neurology 45 255 260 1:STN:280:DyaK2M7lslOnsA%3D%3D 7854522
15. NC Fox R Jenkins SM Leary, et al. 2000 Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI Neurology 54 807 812 1:STN:280:DC%2BD3c7lt1yhtA%3D%3D 10690967
16. C Gasperini MA Horsfield JW Thorpe, et al. 1996 Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters J Magn Reson Imaging 6 580 584 10.1002/jmri.1880060404 1:STN:280:DyaK28vjt12hsw%3D%3D 8835949
17. A Gass GJ Barker D Kidd, et al. 1994 Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis Ann Neurol 36 62 67 10.1002/ana.410360113 1:STN:280:DyaK2c3ps1Sksg%3D%3D 8024264 (Pubitemid 24205825)
18. Y Ge RI Grossman JK Udupa, et al. 2001 Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter Radiology 220 606 610 10.1148/radiol.2203001776 1:STN:280:DC%2BD3MvotlaitQ%3D%3D 11526256 (Pubitemid 32799964)
19. Y Ge RI Grossman JK Udupa, et al. 2000 Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis Radiology 214 665 670 1:STN:280:DC%2BD3c7osV2itQ%3D%3D 10715027
20. AD Gean-Marton LG Vezina KI Marton, et al. 1991 Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis Radiology 180 215 221 1:STN:280:DyaK3M3ntFGmsA%3D%3D 2052698
21. M Hardmeier S Wagenpfeil P Freitag, et al. 2003 Atrophy is detectable within a 3-month period in untreated patients with active relapsing remitting multiple sclerosis Arch Neurol 60 1736 1739 10.1001/archneur.60.12.1736 14676048 (Pubitemid 37521628)
22. JO Harris JA Frank N Patronas, et al. 1991 Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history Ann Neurol 29 548 555 10.1002/ana.410290515 1:STN:280:DyaK3MzhsFWksg%3D%3D 1859184
23. M Hines L Chiu LA McAdams, et al. 1992 Cognition and the corpus callosum: verbal fluency, visuospatial ability, and language lateralization related to midsagittal surface areas of callosal subregions Behav Neurosci 106 3 14 10.1037/0735-7044.106.1.3 1:STN:280:DyaK383gslCjtg%3D%3D 1554435
24. D Horakova JL Cox E Havrdova, et al. 2008 Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study J Neurol Neurosurg Psychiatry 79 407 414 10.1136/jnnp.2007.120378 1:STN:280:DC%2BD1c7otFagtA%3D%3D 17550987 (Pubitemid 351441496)
25. CK Jones A Riddehough DKB Li, et al. 2001 MRI cerebral atrophy in relapsing-remitting MS: Results from the PRISMS Trial Neurology 56 A379
26. NF Kalkers N Ameziane JC Bot, et al. 2002 Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype Arch Neurol 59 1572 1576 10.1001/archneur.59.10.1572 12374494
27. J Kassubek H Tumani D Ecker, et al. 2003 Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study Neuroreport 14 427 430 10.1097/00001756-200303030-00026 12634497
28. D Kidd JW Thorpe AJ Thompson, et al. 1993 Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis Neurology 43 2632 2637 1:STN:280:DyaK2c%2Fnsleruw%3D%3D 8255468 (Pubitemid 24004558)
29. C Liu S Edwards Q Gong, et al. 1999 Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis J Neurol Neurosurg Psychiatry 66 323 330 10.1136/jnnp.66.3.323 1:STN:280:DyaK1M7ot1Shsw%3D%3D 10084530
30. Losseff NA, Wang L, Lai HM et al (1996) Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 119(Pt 6):2009-2019
31. FD Lublin SC Reingold 1996 Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Neurology 46 907 911 1:STN:280:DyaK28zntlOksg%3D%3D 8780061
32. J Martola L Stawiarz S Fredrikson, et al. 2007 Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development J Neurol Neurosurg Psychiatry 78 375 380 17119006
33. DH Miller PS Albert F Barkhof, et al. 1996 Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force Ann Neurol 39 6 16 10.1002/ana.410390104 1:STN:280:DyaK287mtVKhtw%3D%3D 8572668 (Pubitemid 26052212)
34. DH Miller F Barkhof JA Frank, et al. 2002 Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance Brain 125 1676 1695 10.1093/brain/awf177 12135961
35. DH Miller RI Grossman SC Reingold, et al. 1998 The role of magnetic resonance techniques in understanding and managing multiple sclerosis Brain 121 Pt 1 3 24 10.1093/brain/121.1.3 9549485 (Pubitemid 28045503)
36. KM Myhr T Riise C Vedeler, et al. 2001 Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension Mult Scler 7 59 65 1:STN:280:DC%2BD3MvlvFygsA%3D%3D 11321195
37. GJ Nijeholt MA van Walderveen JA Castelijns, et al. 1998 Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms Brain 121 Pt 4 687 697 10.1093/brain/121.4.687 9577394 (Pubitemid 28162129)
38. J Pelletier L Suchet T Witjas, et al. 2001 A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis Arch Neurol 58 105 111 10.1001/archneur.58.1.105 1:STN:280:DC%2BD3M7lsVKitQ%3D%3D 11176943
39. CH Polman SC Reingold G Edan, et al. 2005 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 840 846 10.1002/ana.20703 16283615 (Pubitemid 41746873)
40. M Quarantelli A Ciarmiello VB Morra, et al. 2003 Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load Neuroimage 18 360 366 10.1016/S1053-8119(02)00018-6 12595189 (Pubitemid 36269145)
41. RA Rudick E Fisher JC Lee, et al. 1999 Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group Neurology 53 1698 1704 1:STN:280:DC%2BD3c%2FisFWguw%3D%3D 10563615
42. B Runmarker O Andersen 1993 Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up Brain 116 Pt 1 117 134 10.1093/brain/116.1.117 8453453
43. MP Sanfilipo RH Benedict J Sharma, et al. 2005 The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray versus white matter with misclassification correction Neuroimage 26 1068 1077 10.1016/j.neuroimage.2005.03.008 15961046 (Pubitemid 40806485)
44. J Sharma MP Sanfilipo RH Benedict, et al. 2004 Whole-brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation AJNR Am J Neuroradiol 25 985 996 15205136
45. JH Simon SL Holtas RB Schiffer, et al. 1986 Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR Radiology 160 363 367 1:STN:280:DyaL283mtVKitg%3D%3D 3726114
46. G Tedeschi L Lavorgna P Russo, et al. 2005 Brain atrophy and lesion load in a large population of patients with multiple sclerosis Neurology 65 280 285 10.1212/01.wnl.0000168837.87351.1f 1:STN:280:DC%2BD2MzosFyrsw%3D%3D 16043800 (Pubitemid 41022375)
47. M Tiberio DT Chard DR Altmann, et al. 2005 Gray and white matter volume changes in early RRMS: a 2-year longitudinal study Neurology 64 1001 1007 1:STN:280:DC%2BD2M7kvFOqug%3D%3D 15781816
48. L Truyen JH van Waesberghe MA van Walderveen, et al. 1996 Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis Neurology 47 1469 1476 1:STN:280:DyaK2s7itVSmug%3D%3D 8960729
49. P Valsasina B Benedetti M Rovaris, et al. 2005 Evidence for progressive gray matter loss in patients with relapsing-remitting MS Neurology 65 1126 1128 10.1212/01.wnl.0000178982.53965.70 1:STN:280:DC%2BD2MrktFClsg%3D%3D 16217074 (Pubitemid 41429650)
50. MA van Walderveen F Barkhof OR Hommes, et al. 1995 Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images Neurology 45 1684 1690 7675227
51. H Vrenken JJ Geurts DL Knol, et al. 2006 Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter Radiology 240 811 820 10.1148/radiol.2403050569 16868279 (Pubitemid 44267339)
52. R Zivadinov AT Reder M Filippi, et al. 2008 Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology 71 136 144 10.1212/01.wnl.0000316810.01120.05 1:STN:280: DC%2BD1cvjs1GisA%3D%3D 18606968